Medicinova INC (MNOV) — 10-Q Filings

All 10-Q filings from Medicinova INC. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.

10-Q Filings (6)

MediciNova's Q3 Loss Widens Amid Increased R&D Spend — Nov 12, 2025 Risk: high
MediciNova, Inc. (MNOV) reported a net loss of $3,050,373 for the three months ended September 30, 2025, an increase from a net loss of $2,852,179 for the same
MediciNova's Losses Widen Amid Increased R&D Spend — Aug 14, 2025 Risk: high
MediciNova, Inc. (MNOV) reported a net loss of $3,281,185 for the three months ended June 30, 2025, a 24.8% increase from the $2,628,200 net loss in the same pe
MedicinoVa Inc. Files Q1 2025 10-Q Report — May 13, 2025 Risk: low
MedicinoVa Inc. filed its quarterly report for the period ending March 31, 2025. The company, located at 4275 Executive Square, Suite 300, La Jolla, CA 92037, r
MedicinoVa Inc. Files Q3 2024 10-Q Report — Nov 13, 2024 Risk: low
MedicinoVa Inc. reported its third-quarter results for the period ending September 30, 2024. The company's filing details its financial position and operational
MEDICINOVA INC. Files Q2 2024 10-Q Report — Aug 8, 2024 Risk: low
MEDICINOVA INC. filed its 10-Q for the period ending June 30, 2024. The company's fiscal year ends on December 31st. Key financial data points and equity incent
MEDICINOVA INC Files 10-Q for Period Ending March 31, 2024 — May 9, 2024 Risk: medium
MEDICINOVA INC (MNOV) filed a Quarterly Report (10-Q) with the SEC on May 9, 2024. MEDICINOVA INC filed a 10-Q report for the period ending March 31, 2024. The

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX